Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EBT (2020 - 2025)

Historic EBT for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • Biofrontera's EBT fell 1724.32% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year decrease of 3689.84%. This contributed to the annual value of -$17.7 million for FY2024, which is 1183.08% up from last year.
  • As of Q3 2025, Biofrontera's EBT stood at -$6.6 million, which was down 1724.32% from -$5.3 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's EBT registered a high of $5.6 million during Q1 2022, and its lowest value of -$16.0 million during Q3 2021.
  • In the last 5 years, Biofrontera's EBT had a median value of -$4.2 million in 2025 and averaged -$4.9 million.
  • Its EBT has fluctuated over the past 5 years, first soared by 25825.08% in 2022, then crashed by 213755.27% in 2025.
  • Over the past 5 years, Biofrontera's EBT (Quarter) stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then surged by 226.44% to $3.5 million in 2023, then tumbled by 139.74% to -$1.4 million in 2024, then tumbled by 374.84% to -$6.6 million in 2025.
  • Its EBT was -$6.6 million in Q3 2025, compared to -$5.3 million in Q2 2025 and -$4.2 million in Q1 2025.